Compare HIG & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HIG | GEHC |
|---|---|---|
| Founded | 1810 | 1892 |
| Country | United States | United States |
| Employees | 19200 | N/A |
| Industry | Property-Casualty Insurers | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.9B | 29.1B |
| IPO Year | N/A | 2022 |
| Metric | HIG | GEHC |
|---|---|---|
| Price | $128.20 | $61.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 13 |
| Target Price | ★ $148.47 | $88.38 |
| AVG Volume (30 Days) | 1.5M | ★ 4.2M |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.76% | 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $6.05 | $7.12 |
| Revenue Next Year | $4.13 | $4.45 |
| P/E Ratio | ★ $10.61 | $72.47 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $119.61 | $58.75 |
| 52 Week High | $143.98 | $89.77 |
| Indicator | HIG | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 43.13 | 41.63 |
| Support Level | $127.75 | $60.80 |
| Resistance Level | $138.37 | $64.99 |
| Average True Range (ATR) | 2.52 | 1.80 |
| MACD | 0.26 | -0.06 |
| Stochastic Oscillator | 39.58 | 27.20 |
The Hartford Insurance Group Inc. provides property and casualty insurance, group benefits, and mutual funds. The company is widely recognized for its service excellence, sustainability practices, trust, and integrity. The Company currently conducts business principally in five reportable segments, including Business Insurance, Personal Insurance, Property & Casualty Other Operations, Employee Benefits, and Hartford Funds, as well as a Corporate category. The company generates a majority of its revenue from Business Insurance.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).